Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer

Urology

Volumn 51, Issue 1, 1998, Pages 44-50

  Van Der Poel, H G ^a,c   Van Balken, M R ^a,c   Schamhart, D H J ^b,c   Peelen, P ^a,c   De Reijke, Th ^b,c   Debruyne, E M J ^c   Schalken, J A ^a,c   Witjes, J A ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CARCINOMA IN SITU; CYSTOSCOPY; CYTOLOGY; HUMAN; IMAGE ANALYSIS; KARYOMETRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, TRANSITIONAL CELL; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0031891795     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00496-2     Document Type: Article

References (18)

1. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne FMJ, Pavone-Macaluso M, and Oosterlinck W: Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 31a: 1840-1846, 1995.
2. Hall RR, Parmar MKB, Richards AB, and Smith PH: The cystoscopic follow up of patients with Ta.T1 bladder carcinoma and the role of adjuvant intravesical therapy: a proposal. Br Med J 308: 257-260, 1994.
3. Westenfelder M, Rosset K, and Pelz K: Development of nosocomial and iatrogenic urinary tract infections (UTI) following urological interventions. A prospective clinical study. Scand J Urol Nephrol Suppl 104: 59-63, 1987.
4. Zein T, Waisman Z, Englander LS, Gamarra M, Lopez C, Huben RP, and Pontes JE: Evaluation of bladder washings and cytology for the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 132: 670-671, 1984.
5. Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, and Soloway MS: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 136: 815-819, 1986.
6. Sherman AB, Koss LG, and Adams SE: Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal Quant Cytol Histol 6: 112-118, 1984.
7. van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FMJ, and Schalken JA: QUANTICYT: karyometric analysis of bladder washing for patients with superficial bladder cancer. Urology 48: 357-364, 1996.
8. Böcking A, Adler CP, Common HH, Hilgarth M, Granzen B, and Auffermann W: Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol 6: 1-8, 1984.
9. Sarosdy MF, deVere-White RW, Soloway MS, Sheinfeld J, Hudson MA, Schelhammer PF, Jarowenko MV, Adams G, and Blumenstein BA: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379-383, 1995.
10. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, Lange P, Messing E, Pasciak RM, Reservitz GB, et al: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363-367, 1996.
11. Amberson JB, and Laino JP: Image cytometric deoxyribonucleic acid analysis of specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma. J Urol 149: 42-45, 1993.
12. Rübben H, Graf-Dobberstein C, Ostwald R, Stauffenberg A, Jaeger N, Deutz FJ, Steffens L, and Gianni G: Prospective randomized study of adjuvant therapy after complete re-section of superficial bladder cancer: Mytomycin C versus BCG Connaught versus TUR alone, in deKernion JB (Ed): Immunotherapy of Urological Tumors. Edinburgh: Churchill Livingstone, 1990, pp 27-36.
13. Heney NM, Ahmed S, Flanagan MJ, Erable W, Corder MP, Hafermann MD, and Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983.
14. Cutler SJ, Heney NM, and Friedell GH: Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression, in Bonney WW, and Prout GR: Bladder Cancer, AUA Monograph 1982, vol I: 35-42.
15. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, and Debruyne FMJ: Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150: 60-64, 1993.
16. D'Hallewin MA, and Baert L: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475-476, 1996.
17. Sarosdy MF: The use of the BTA test in the detection of persistent or recurrent transitional-cell cancer of the bladder. World J Urol 15: 103-106, 1997.
18. The United Kingdom and Eire Bladder Tumour Antigen Study Group: The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer. Br J Urol 79: 362-366, 1997.